Literature DB >> 2994446

Neoplastic diseases of the haemopoietic system in Ibadan: preliminary report of a prospective study.

C K Williams.   

Abstract

The clinical and epidemiological features of haemopoietic malignancies in Ibadan have been evaluated in this preliminary analysis on findings on 113 patients seen at the University College Hospital, Ibadan, Nigeria, from July 1978 to June 1981. Twenty-seven patients had acute myelogenous (AML), twenty-two acute lymphoblastic (ALL), thirty-one chronic myelocytic (AML), thirty-one chronic lymphocytic leukaemia (CLL), two had polycythaemia rubra vera (PRV) and one myelofibrosis (MF). Incidence rates (IR) of 0.9 X 10(-5) and 1.9 X 10(-5) were estimated for acute leukemia (AL) and all leukemia subtypes respectively. Chloroma occurred frequently in association with AML especially in childhood, and CLL in elderly patients (greater than 50 years) and ALL appeared to manifest unusually aggressive features in spite of apparently adequate chemotherapy. Some of these clinical and epidemiological features suggest deviant biology of some haemopoietic malignancies in Ibadan.

Entities:  

Mesh:

Year:  1985        PMID: 2994446

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  3 in total

1.  Haematology in Africa.

Authors:  Lucio Luzzatto; Foluke Fasola; Léon Tshilolo
Journal:  Br J Haematol       Date:  2011-07-05       Impact factor: 6.998

2.  Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis.

Authors:  Christopher Ko Williams; Letizia Foroni; Lucio Luzzatto; Idris Saliu; Arthur Levine; Mel F Greaves
Journal:  Ecancermedicalscience       Date:  2014-11-06

3.  Presentation and survival in patients with hematologic malignancies in Jos, Nigeria: A retrospective cohort analysis.

Authors:  Ochaka J Egesie; Patricia A Agaba; Olugbenga A Silas; Chad Achenbach; Ayuba Zoakah; Oche O Agbaji; Jeremiah A Madaki; Edith N Okeke; Lifang Hou; Atiene S Sagay; Robert Murphy
Journal:  J Med Trop       Date:  2018-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.